Impladent is proud to offer our "50/50" Cortical / Cancellous. When it comes to bone grafting procedures, having the right bone graft material is essential for successful outcomes. We are excited to introduce our advanced "50/50" Cortical/Cancellous Allograft from Impladent, a cutting-edge solution designed to support bone regeneration effectively. It features:
- "50/50" Corticocancellous Irradiated Mineralized Bone Matrix (MBM) Allograft
- Corticocancellous Mineralized Bone Matrix Allograft in one vial
- Particle size: .250 - 1.00mm
- Human Allograft Material provides osteoconductive and osteoinductive matrix
- Stimulates bone formation while providing a scaffold for new bone growth
- Tissue processing in accordance with AATB standards and FDA regulations
- Available in 1.0cc, 2.0cc and 5.0cc vials
Product Description:
Reconstitution Sheet and Patient Tracking Form
This product contains Human Allograft Material (referred to as “Graft”) collected from human cadaveric donors.
All tissue processed for Impladent Ltd. is recovered by U.S. tissue banks as well as a completed donor chart for the enclosed product including but not limited to: serology results, preprocessing culture results, medical and social history evaluation and serodilution calculations that are conducted by or contract tested for the tissue bank. It has been reviewed and approved for transplantation by the tissue bank’s Medical Director.
Donor screening and testing are performed in accordance with the American Association of Tissue Banks (AATB) standards and U.S. Food and Drug Administration (FDA) regulations. All processing documentation has been reviewed and approved by the tissue bank’s Quality Assurance department; each lot of product is manufactured using tissue from a single donor. There is no pooling of donor tissue.
A donor serum sample is tested by a CLIA Certified Lab using FDA licensed screening tests and found to be negative or non-reactive for antibodies to human immunodeficiency virus type 1 and type 2 (anti-HIV 1 and anti-HIV 2), hepatitis B surface antigen (HbsAg), hepatitis B core antibody (HbcAb), antibodies to the hepatitis C virus (anti-HCV), and the human T-lymphotrophic virus type I antibody (anti-HTLV I). The serum tests are negative for syphilis using a FDA licensed confirmatory test. The donor also tests negative for HIV using Polymerase Chain Reaction (PCR) technology or an FDA-licensed NAT test.
Our "50/50" Cortical/Cancellous Allograft combines the benefits of cortical and cancellous bone to provide optimal bone healing and regeneration. This unique combination offers an ideal balance of structure, strength, and growth factors, promoting the natural regrowth of bone tissue for your patients.
Our allograft is precisely formulated to maintain a 50/50 ratio of cortical to cancellous bone. This optimal balance provides the necessary support for bone structure and stability, while also allowing for efficient nutrient exchange, cellular infiltration, and new bone formation.
The "50/50" Cortical/Cancellous Allograft is versatile and suitable for a wide range of bone grafting procedures, including socket preservation, ridge augmentation, periodontal defects, and sinus lifting. Its adaptability makes it an excellent choice for various dental and maxillofacial applications.
Enhanced Healing Potential: The allograft is meticulously processed to remove potential contaminants while preserving the natural osteoinductive and osteoconductive properties of the bone matrix. This preservation ensures that our allograft stimulates new bone growth, accelerates healing, and promotes successful integration with the patient's existing bone.
Choose Impladent Today's "50/50" Cortical/Cancellous Allograft and offer your patients the best chance for successful bone regeneration. Give them the gift of renewed bone structure and function. Order online today.
- Advanced technology
- Superior quality
- Fast shipping
